Michael Grothaus / Fast Company
Johnson Johnson will buy medtech maker Abiomed in a $16.6 billion deal – JNJ says its looking to strengthen its position as a solutions provider for the worlds top cause of deathcardiovascular disease. Johnson Johnson has announced that it is acquiring the Danvers, Massachusetts-based medical technology company Abiomed for $16.6 billion. Heres what you need to know: Read Full Story …
